Introduction
Several population-based studies have shown that impaired lung function as measured by forced vital capacity (FVC) or forced expiratory volume in 1 second (FEV1) is a powerful predictor of nonfatal ischemic heart disease and of mortality due to cardiovascular disease (1) (2) (3) (4) .
The relationship between reduced FEV1 and cardiovascular mortality also exists in lifetime nonsmokers (2) , and even a modest decline in FEV1 is associated with a substantial increase in death from coronary artery disease (2) . Furthermore, annual decline of FEV1, independent of baseline FEV1, is also related to cardiovascular mortality (5) .
The majority of patients with reduced FEV1 have asthma, chronic obstructive pulmonary disease (COPD) or fibrotic lung disease (6) . In these conditions, cytokines are overexpressed in lung tissue, potentially resulting in systemic low-grade inflammation (6) (7) (8) (9) . This led to the suggestion that inflammation is an important pathway between lung disease and vascular disease (2, 6) . However, increased levels of systemic markers of inflammation have only been demonstrated mainly when patients with overt airflow limitation were compared to subjects without pulmonary impairment (6, 7, 10) .
The lung is particularly dependent on tightly regulated immunological and inflammatory processes since it is exposed to a large and varied burden of infectious agents as well as a diverse group of noxious gases and particulates during the process of gas exchange. Consequently, the lung has a large number of resident macrophages that generate various inflammatory mediators and cytokines (11) (12) (13) . Thus, the lung may be a source for low-grade systemic inflammation in the absence of overt pulmonary disease.
The relationship between ventilatory function and markers of systemic inflammation such as C-reactive protein (CRP) is affected by several factors that are associated with subclinical 4 systemic inflammation including smoking, obesity and reduced cardiorespiratory fitness (14) (15) (16) .
In the present cross-sectional study, we sought to determine whether differences in pulmonary function within the normal range are associated with CRP concentrations, and whether this association is independent of factors that affect both ventilatory function and plasma CRP.
Methods
The following is an abridged version of the Methods. The full text appears in the online supplement.
Subjects:
We studied middle-aged subjects who reported to the Rambam Center for Preventive Medicine for a medical examination and health counseling. The investigational review committee on human research approved the study. All subjects enrolled in the study signed a statement agreeing to the use of their medical information for research purposes.
Definitions: Categories of body mass index (BMI) were constructed based on the World Health Organization expert committee classification (17) . Characteristics of the metabolic syndrome were defined as previously described (18) . Cigarette smoking was trichotomized into never-smokers, former smokers and current smokers by use of standard questionnaire.
Fitness was quantified using a maximal exercise test with the Bruce protocol (19) as previously described (18) . Cardiorespiratory fitness was categorized based on sex-specific tertiles. High-sensitivity CRP was measured as previously described (18) .
Pulmonary function tests:
Pulmonary function testing was performed using a computerized Pneumotach Jaeger spirometer (Hoechberg, Germany). Before testing, the spirometer was calibrated according to the recommendations of the American Thoracic Society (20) . Specially trained technician performed the tests. FVC and FEV1 were recorded for at least three FVC maneuvers, and the best FEV1 was used for analysis. Published prediction equations 5 were used to calculate predicted FEV1, FVC, and peak expiratory flow (PEF) for each participant (21) . Percentage of the predicted FEV1 (FEV1 %pred) were calculated, and each subject was classified into quartiles of FEV1 %pred. FEV1/FVC ratio of less than 0.7 was used to define airflow obstruction (13) .
Statistical Methods:
The baseline characteristics of the groups were compared using analysis of variance for continuous variables and by the χ 2 statistic for noncontinuous variables. In addition, geometric means of CRP were calculated using two-way analysis of covariance, with ln CRP as the dependent variable, quartiles of FEV1 as one factor and categories of BMI as the other. Similar models were fitted with quartiles of FEV1 and fitness level.
Multivariate logistic regression was used to examine the association between the metabolic syndrome and high risk CRP, defined as CRP > 3.0 mg/L (22) , in relation to quartiles of pulmonary function tests.
All multivariate models were adjusted for smoking status. In addition, to exclude the possibility of confounding by smoking-induced respiratory disease, all multivariate model were repeated in the subgroup of never-smokers (n=734). All statistical analyses were performed using the SPSS statistical software Version 12.0 (Chicago, IL).
Results
The study population included 1131 subjects (mean age 50 ± 9 years [range 25-82], 24% females). Ninety-six of the study participants (8.5%) had FEV1 %pred of less than 80% and only 4 participants had evidence of airflow obstruction (0.4%). The clinical characteristics of the study participants according to FEV1 %pred are presented in Table 1 . Study participants with lower FEV1 %pred values were more likely to be men and have a history of smoking. The prevalence of some of the characteristics of the metabolic syndrome including obesity, elevated triglyceride levels, and glucose intolerance were higher in participants with lower FEV1 %pred.
Positive criteria for the diagnosis of the metabolic syndrome were higher in subjects with lower FEV1 %pred values (Table 1 ). Figure 1A shows that the percentage of study participant who were in the upper fitness tertile was lowest among subjects with the lowest FEV1 %pred, and highest among subjects with the highest FEV1 %pred. In an ANCOVA model adjusting for age, gender, smoking status and BMI, fitness level increased with increasing quartiles of predicted FEV1 (P for trend < 0.0001; Figure 1B ). and CRP was present when the analyses were repeated using quartiles of FVC (see Figure E1 in the online data supplement) and quartiles of PEF (P < 0.0001), but not with quartiles of FEV1-7 FVC ratio (P = 0.59).
Relationship
Adjusted geometric mean CRP were computed in analyses in which study participants were stratified into 12 groups according to FEV1 quartile and 3 BMI categories. Two-way ANCOVA main effects indicated a significant inverse association between CRP and FEV1 quartile (P < 0.0001) and a direct association between CRP and BMI (P < 0.0001). For each category of BMI, the adjusted geometric mean CRP was lowest among subjects with the highest FEV1 and highest among subjects in the lowest FEV1 quartile ( Figure 3 ). Similar results were obtained when never-smokers (n = 734; P = 0.004 for the main effect of FEV1 quartile) and subject without diabetes (n=1015; P = 0.003 for the main effect of FEV1 quartile) were analyzed separately.
The relationship between FEV1 and BMI was also tested in 3 separate models for each BMI category. The inverse relationship between CRP levels and FEV1 quartiles was present in all 3
BMI groups: subjects with normal BMI, P = 0.01; Overweight subjects, P < 0.0001; and Obese subjects, P = 0.001. The results of the multivariate linear regression analysis of the fully adjusted model (age, sex, drug use, history of coronary disease, smoking, metabolic abnormalities and fitness level)
are shown in Table 2 . A highly significant inverse association was observed between CRP and quartiles of FEV1. Similar results were obtained when the analyses were repeated using 8 continuous rather than categorical variables for FEV1 (P < 0.0001), cardiorespiratory fitness (P = 0.03), and components of the metabolic syndrome including BMI (P < 0.0001) and HDL cholesterol (P < 0.0001).
The frequency of high-risk CRP (>3 mg/L) was 50%, 38%, 29% and 26% in the first, second, third and forth FEV1 quartile, respectively (P < 0.0001). Multivariate logistic regression models were developed to determine the relationship between quartiles of FEV1 and the presence of high-risk CRP ( Figure 5 ). Compared to subjects at the highest FEV1 quartile, the adjusted odds for high-risk CRP level were 2.5 in subjects in the first FEV1 quartile (95% CI 1.50-4.0, P < 0.0001). In never-smokers, the adjusted odds for high-risk CRP level were 2.3 in subjects in the first FEV1 quartile (95% CI 1.4-3.8, P = 0.001).
Discussion
The results of the present study show that measures of pulmonary function are inversely related to plasma concentrations of CRP. The inverse association between pulmonary function and CRP was independent of factors known to influence CRP levels such as smoking, components of the metabolic syndrome, and cardiorespiratory fitness. Inverse linear associations between quartiles of FEV1 and CRP were observed within subsets of individuals with different degrees of metabolic perturbations and subjects with different level of cardiorespiratory fitness.
Furthermore, the inverse association between pulmonary function and CRP was also present in the subgroup of never-smokers.
The lung has a large number of resident macrophages involved in innate protection of the pulmonary tree against inhaled microorganisms and other noxious particulate matter. These include tobacco smoke, infectious agents, occupational dusts and chemicals, and particulate air pollution. Subjects with lower FEV1 may have higher exposure to tobacco smoke or to environmental insults that lead to a subtle decline in lung function and, in parallel, induce a lowgrade inflammatory response. It has long been recognized that smoking is associated with airway inflammation (12, 23) . In never-smokers, other mechanisms may induce subclinical inflammation. For example, there is a systemic response to inhalation of fine atmospheric particles, initiated by cytokines generated by lung macrophages that phagocytose particles deposited on the lung surface. These cytokines modulate local inflammatory responses and enter the circulation, where they stimulate the liver to release acute phase proteins (24, 25) . Such a mechanism may explain the finding of elevated levels of CRP in people during times of increased particulate air pollution (24, 26, 27) . Airspace inflammation leading to the release of proinflammatory cytokines (e.g. interleukin-6) from alveolar macrophages may also occur due to subclinical respiratory infection and lead to systemic inflammation (28).
However, because objective evidence for pulmonary inflammation was not available, our study cannot determine whether the inverse association between CRP and measures of lung function is due to intrapulmonary inflammation. In addition to environmental exposures, individual variations in ventilatory function are likely to be influenced by genetic factors. People with a genetic predisposition for an exaggerated inflammatory response to an environmental or infectious insults (29) may be at higher risk for deterioration of their pulmonary function. Thus, the inverse association between pulmonary function and CRP may also be partly mediated by some unfavorable genetic characteristics conferring increased susceptibility for inflammationmediated lung injury.
Although the association between impaired lung function and cardiovascular disease is well recognized (1-4), the mechanism is unclear. Recently, evidence for systemic inflammation has been demonstrated in patients with overt airflow limitation. Several studies have shown an inverse association between pulmonary function tests and levels of inflammation sensitive plasma proteins (fibrinogen, α1-antitrypsin, haptoglobin, and ceruloplasmin) (10, 30) . Two studies reported an association between elevated CRP (as assessed by a nonsensitive assay) and lung disease using data from the Third National Health and Nutrition Examination Survey (NHANES III). Mannino and collogues reported that the frequency of CRP level ≥ 3 mg/L was higher in patients with moderate or severe COPD and in patients with restrictive lung disease (6).
Sin et al. reported that individual with moderate or severe airflow obstruction were more likely to have an elevated (≥ 2.2 mg/L) circulating CRP level (7).
The results of the present study extend these findings by demonstrating an inverse linear relationship between CRP and measures of pulmonary function in subjects without pulmonary disease and in never-smokers. These finding are important because they may increase our understanding of the link between respiratory impairment and cardiovascular risk. Inflammation is a common pathway for obstructive and several forms of restrictive lung disease. For example, COPD is characterized by chronic inflammation throughout the airways, parenchyma, and pulmonary vasculture, with inflammatory cells producing a variety of proinflammatory cytokines (13) . Although subjects in the present study are unlikely to develop COPD, our findings suggest that low-grade inflammation accompanies the reduction in ventilatory function in the preclinical stage of COPD. Thus, because clinically overt lung disease is preceded by a long period of progressive decline in ventilatory function, elevation of CRP and other proinflammatory mediators may contribute to subsequent risk of coronary heart disease even before overt lung disease develops (31) .
Previous studies have shown that obesity is negatively associated with lung function in healthy adults (14, 15) . Additionally, there is an association between physical activity and slower rate of age-related FEV1 decline (16) . Both obesity (32) and low cardiorespiratory fitness (33) are strongly related to increased CRP levels. Whereas the relationship between ventilatory function and CRP was independent of these factors, the coexistence of reduced pulmonary function and obesity or reduced cardiorespiratory fitness greatly increases CRP concentrations.
Inflammation is important in the initiation, progression, and clinical outcome of atherosclerosis (31) . Prospective studies have shown an association between CRP levels and long-term risk of cardiovascular disease (34) . CRP is thought to be a distal indicator of inflammation that reflects the consequence of distinct inflammatory processes of nonvascular or vascular origin (35) . Such inflammatory processes lead to elevated levels of proinflammatory cytokines or other products that have a causal role in atherogenesis or instability of atherosclerotic plaques (35, 36) . However, the stimuli that trigger CRP production and causes of low-grade inflammation in apparently healthy subjects are incompletely understood (35, 36) .
Raised CRP concentrations are strongly associated with BMI (32), reflecting the fact that adipose tissue is an important source of cytokines (37) , and produces approximately 25% of basal circulating interleukin-6 (37), the principal cytokine that induces the acute-phase response.
Other potential low-grade inflammatory processes that lead to increased CRP include fatty infiltration of the liver (38) and inflammation within the arterial wall. The results of the present study suggest that intra pulmonary inflammation is another possible nonvascular trigger for lowgrade inflammation.
Study limitations:
Measures of pulmonary function such as FEV1 are highly influenced by the voluntary effort exerted in performing the maneuver. However, despite the potential for measurement error in assessing lung function, the strong independent relationship between pulmonary function and CRP suggests that such measurement error would lead to 12 underestimation of the true effect.
There was no measurement of local lung inflammation such as bronchoalveolar lavage or sputum analyses in our study. Thus, our data does not directly show that lung inflammation underlies the association between reduced pulmonary function tests and CRP. Our study used a cross-sectional design and lacked cardiovascular morbidity and mortality endpoints. Further understanding of the complex interaction between pulmonary function, low-grade inflammation and their association with cardiovascular disease should be obtained from longitudinal studies that measure pulmonary function, inflammatory markers and cardiovascular morbidity and mortality endpoints.
We measured CRP level at a single time point and therefore cannot exclude the possibility of intra-individual changes in CRP level with repeated measurements (22) . However, such misclassification of should lead to an underestimation of the relationship between pulmonary function and CRP.
Conclusion: An inverse linear relationship exists between CRP concentrations and
measures of pulmonary function in subjects without pulmonary disease and in never-smokers.
These results indicate that systemic inflammation may be linked to early perturbations of pulmonary function. Age, years 51 ± 9 49 ± 10 49 ± 9 51 ± 9 0.92
Figure legends
Female, % 54 (19) 64 (23) 69 (24) 89 (31) Fitness was quantified using a maximal exercise test with the Bruce protocol (E2) as previously described (E3). Cardiorespiratory fitness was categorized based on sex-specific 2 tertiles. High-sensitivity CRP was measured as previously described (E3).
Pulmonary function tests:
Pulmonary function testing was performed using a computerized Pneumotach Jaeger spirometer (Hoechberg, Germany). Before testing, the spirometer was calibrated according to the recommendations of the American Thoracic Society (E4). Specially trained technician performed the tests. FVC and FEV1 were recorded for at least three FVC maneuvers, and the best FEV1 was used for analysis. Published prediction equations were used to calculate predicted FEV1, FVC, and peak expiratory flow (PEF) for each participant (E5). Percentage of the predicted FEV1 (FEV1 %pred) were calculated, and each subject was classified into quartiles of FEV1 %pred. FEV1/FVC ratio of less than 0.7 was used to define airflow obstruction (E6).
Statistical Methods:
The baseline characteristics of the groups were compared using analysis of variance for continuous variables and by the χ 2 statistic for noncontinuous variables.
The distribution of CRP levels was highly skewed. Therefore, CRP values were transformed to their natural logarithm (ln CRP) for all other analyses. The adjusted mean values of ln CRP in relation to quartiles of pulmonary function tests were calculated by analysis of covariance (ANCOVA), with results expressed as geometric means. Geometric means of CRP were adjusted for age, gender, smoking status, use of statins and aspirin, history of coronary artery disease, components of the metabolic syndrome (presence of obesity, glucose intolerance, hypertension, low HDL-cholesterol and elevated triglycerides), and fitness level.
In addition, geometric means of CRP were calculated using two-way analysis of covariance, with ln CRP as the dependent variable, quartiles of FEV1 as one factor and categories of BMI as the other. Similar models were fitted with quartiles of FEV1 and fitness level.
Multivariate logistic regression was used to examine the association between the metabolic 3 syndrome and high risk CRP, defined as CRP > 3.0 mg/L (E7), in relation to quartiles of pulmonary function tests.
Figure legend
Figure 1E: Box-and-whisker plots of crude CRP levels across quartiles of FVC in study participant with and without a history of smoking (P for trend < 0.0001 for both groups). The line within the box denotes the median and the box spans the interquartile range (25th to 75th percentiles). Whiskers extend from the 10th to 90th percentiles.
